The following is a guest article by Mohammad Alsaadany, Regional Director at BioNixus
It usually surfaces on a Tuesday.
A revenue-cycle director opens the overnight ticket queue and notices denial workups stamped at 3 a.m. local time. The outside billing team is doing what they were hired to do. Then someone in privacy asks: where exactly are those people sitting when they open the chart?
Plenty of U.S. hospitals and specialty practices use offshore or nearshore RCM help. The staffing math works. What often lags is who can see what, from which country, under whose controls, and with what paper trail when something goes sideways.
Arun Anandhan’s recent checklist on this site put it cleanly: once an outside billing team needs EHR or practice-management access, the project is no longer only a staffing decision. It becomes an access and governance decision too. When that team sits overseas, another layer shows up — data residency and cross-border handling under your contracts and payer rules.
Access Control is Not Residency — and a BAA is Not Either
I spend a lot of time in MENA and Gulf markets talking with hospital operators, privacy leads, and vendors about health data. One distinction keeps getting blurred.
Access control answers who can open a record and what they can do inside the system: role-based permissions, unique logins, audit logs, break-glass for emergencies.
Residency answers where the data is stored and processed, and whether it may leave a jurisdiction at all. You can have tight access controls and still move protected health information (PHI) into a place your counsel never modeled. You can keep servers in-country and still give a broad remote login to someone who exports a claim file to a laptop abroad.
A business associate agreement sits in a third bucket. Under HIPAA, a BAA binds the vendor to Privacy, Security, and Breach Notification obligations. It does not decide which countries may access or store PHI. HIPAA does not ban offshore work; it expects safeguards, a risk analysis that accounts for location, and oversight that matches how the work runs. A signed BAA is not proof of residency.
What Stricter Regimes Force You to Ask Earlier
Gulf and MENA privacy and health-data rules vary by country. Personal-data laws in the region typically regulate cross-border transfers with conditions. In some markets, health-sector rules go further and limit where clinical data may be stored or processed outside the country except along approved paths. The details differ — buyers should not treat “PDPL” (personal data protection law) as a single residency statute — but the effect is the same: vendors get asked sooner about geography, subcontractors, and whether work is remote viewing or actual data movement. Those questions help U.S. organizations even when Gulf law does not apply.
At BioNixus, our fieldwork is market research — interviews with operators, IT, and compliance leads across the region — not running billing shops. What I keep hearing is less fear of “offshore” as a label, and more whether anyone can draw a diagram of the actual data path. If the diagram is fuzzy, the contract usually is too.
A Cross-Border Checklist Beyond Basic Access Hygiene
Anandhan covers the foundation: individual credentials, least privilege, rules for data that leaves the system, a BAA that matches the real workflow, and reporting that shows whether RCM is improving. Borrow that. Then add a residency lens before you widen EHR or PM access overseas.
- Map Viewing Versus Moving: Which roles only view inside the EHR or a secure desktop, and which create files that leave it? If everyone downloads, you have hope, not a control model.
- Name Approved Geographies: Countries for staff, cloud regions for intermediate tools, locations for backups. “Anywhere our vendor operates” is not a location.
- Lock the Exit Ramps: Control print, export, USB, personal email, and consumer chat for offshore roles. Write screenshot rules down if you allow them.
- Chain Subcontractors and Log Origin: Disclose every party that can see PHI, including overflow shops. Flow down the same geography rules. Capture source IP or equivalent so you can answer “from where?”
- Align Payer Contracts and Prove Offboarding: Medicare Advantage, Medicaid, and commercial agreements often restrict offshoring even when HIPAA does not. Check those clauses before go-live. When someone leaves the vendor account, access should die the same day — with proof.
Questions to Ask Your RCM Vendor This Week
Ask for written answers, not a call summary.
- In which countries will staff access our EHR or PM system, and is that list contractual?
- Will PHI ever be stored, cached, or backed up outside the U.S. — including screenshots and ticketing attachments?
- Which subcontractors touch our PHI, and where do they sit?
- Can offshore roles be blocked from download, print, and local save?
- How quickly are credentials revoked when a worker leaves, and what evidence do you give us?
- Can your audit logs show user, role, action, and session origin for a sample denial week?
If answers are vague, pause the access expansion.
Residency as a Mirror, Not a Scare Story
What stricter residency conversations do well is force an explicit answer many U.S. teams still leave unfinished: if work happens overseas, what data moves, what stays put, and who can prove it?
Use that mirror. The overnight queue is real, the PHI is real, and the audit request will arrive on a busy day. Offshore RCM can be a solid operating choice. Soft governance of EHR access ages badly.
About Mohammad Alsaadany
Mohammad Alsaadany is Regional Director at BioNixus, a global market research firm with offices in the U.S. and the U.K. and deep experience covering emerging markets, including MENA, GCC, and Latin America (LATAm), with strong coverage of healthcare, pharma, and life sciences. He works with hospital, privacy, and commercial stakeholders on how health data and local regulation shape operating decisions. His fieldwork spans interviews and market studies across these regions rather than product sales.
No comments:
Post a Comment